This inventor holds 1 USPTO granted patent. Top assignee: Pliva D.d.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Jacob J Clement: Innovator in Antibacterial Compounds
Introduction
Jacob J Clement is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of antibacterial research through his innovative work on heterocyclic compounds. His inventions focus on developing inhibitors that target critical enzymes in bacterial cell-wall synthesis.
Latest Patents
Jacob J Clement holds a patent for "Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors." This invention relates to D-Ala-D-Ala ligase inhibitors that possess antibacterial properties. The compounds are designed to bind and inhibit D-Ala-D-Ala ligase, which is essential for bacterial cell-wall synthesis. This innovative approach has potential applications in various antibacterial treatments.
Career Highlights
Jacob J Clement is currently associated with Pliva D.d., a company known for its focus on pharmaceutical development. His work at Pliva has allowed him to explore and develop new antibacterial compounds that can address pressing health challenges.
Collaborations
Jacob has collaborated with notable colleagues, including Paul J Ala and Janid A Ali. These collaborations have contributed to the advancement of research in the field of antibacterial agents.
Conclusion
Jacob J Clement's work in developing D-Ala-D-Ala ligase inhibitors showcases his commitment to innovation in antibacterial research. His contributions are vital in the ongoing fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile